Grupo Español De Linfomas Y Transplante Autólogo De Médula Ósea

This study is testing a personalized cell therapy called axicabtagene ciloleucel (a type of CAR-T) in patients whose aggressive lymphoma has returned more than a year after their first treatment. The trial aims to see if this one-time infusion can lead to long-term remission. Abo…

This study is testing a combination of two drugs, pirtobrutinib and rituximab, for adults newly diagnosed with a slow-growing form of mantle cell lymphoma, a type of blood cancer. The goal is to see if this drug pair can effectively control the disease while causing fewer side ef…